Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Batya Davidovici is active.

Publication


Featured researches published by Batya Davidovici.


British Journal of Dermatology | 2007

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms : does a DRESS syndrome really exist?

S. H. Kardaun; A. Sidoroff; L. Valeyrie-Allanore; Sima Halevy; Batya Davidovici; M. Mockenhaupt; Jean-Claude Roujeau

ulceration. Dis Colon Rectum 2005; 48:1442–6. 4 Egred M, Andron M, Morrison WL. Nicorandil may be associated with gastrointestinal ulceration. BMJ 2006; 332:889. 5 King PM, Suttie SA, Jansen JO, Watson AJM. Perforation of the terminal ileum: a possible complication of nicorandil therapy. Surgeon 2004; 2:56–7. 6 Watson A, Al-Ozairi O, Fraser A et al. Nicorandil associated anal ulceration. Lancet 2002; 360:546–7.


Journal of Burn Care & Research | 2011

Evaluation of SCORTEN on a Cohort of Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Included in the RegiSCAR Study

Peggy Sekula; Yvonne Liss; Batya Davidovici; Ariane Dunant; Jean-Claude Roujeau; Sylvia H. Kardaun; Luigi Naldi; Martin Schumacher; Maja Mockenhaupt

The purpose of this study was to evaluate the severity-of-illness score called SCORTEN with respect to its predictive ability and by using data obtained in the RegiSCAR study, the most comprehensive European registry of patients with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). For advanced comparisons, an auxiliary score (AS) was defined using data obtained in a previous study. Three hundred sixty-nine patients with SJS/TEN were included in RegiSCAR between 2003 and 2005. The data needed for calculation of SCORTEN were available for 45% of patients. The score revealed a moderate predictive ability with a slight underestimation of the total number of in-hospital deaths by 11%, an area under the receiver operating characteristic curve of 0.75, and a Brier score of 0.14. Problems could be seen by analyzing subgroups such as patients with TEN. The AS was better calibrated but discriminated worse (area under the receiver operating characteristic curve: 0.72; Brier score: 0.14). With the help of a refined score derived from SCORTEN and AS, potential for a possible improvement could be demonstrated. The authors were able to show that the predictive ability of SCORTEN is acceptable. Although improvement might be possible, SCORTEN remains the tool of choice, whereas AS might be an alternative in retrospective settings with missing laboratory data.


British Journal of Dermatology | 2010

The spectrum of histopathological features in acute generalized exanthematous pustulosis : a study of 102 cases

Sima Halevy; Sylvia H. Kardaun; Batya Davidovici; J. Wechsler

Background  Acute generalized exanthematous pustulosis (AGEP) is a rare severe pustular reaction pattern with a typical clinical picture.


Archives of Pathology & Laboratory Medicine | 2000

Early Peripheral Lymph Node Involvement of Human Herpesvirus 8–Associated, Body Cavity–Based Lymphoma in a Human Immunodeficiency Virus–Negative Patient

Samuel Ariad; Daniel Benharroch; Lilliana Lupu; Batya Davidovici; Nicolas Dupin; Chris Boshoff

Human herpesvirus 8 (HHV-8), or Kaposi sarcoma-associated herpesvirus, is a gamma herpesvirus first detected in a specimen of Kaposi sarcoma from a human immunodeficiency virus (HIV)-positive patient. Human herpesvirus 8 is also found in an unusual clinicopathologic form of body cavity-based B-cell lymphoma, which has been named primary effusion lymphoma (PEL) and occurs primarily in HIV-positive patients. PEL is characterized by the formation of lymphomatous effusions, without obvious lymphadenopathy, tumor masses, or bone marrow involvement. Only a few cases of PEL in HIV-seronegative patients have been reported. We describe a case of an HHV-8-associated lymphoma, with ascites, pleural effusion, and axillary lymphadenopathy in an HIV-negative patient. The patient was a 68-year-old Jewish man of North African extraction, with a previous history of coronary bypass surgery and multiple blood transfusions. The pleural fluid contained large atypical lymphoid cells and was suggestive of lymphoma but could not provide a conclusive diagnosis of PEL. The lymph node contained groups of large anaplastic lymphoid cells. Polymerase chain reaction for HHV-8 performed on the lymph node specimen was positive, establishing the diagnosis of PEL. Polymerase chain reaction for Epstein-Barr virus was negative. Results of a gallium scan were normal. The patient did not respond to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine sulfate, and prednisone and progressively developed, massive intra-abdominal solid tumor formation. To our knowledge, this is the first report of a case of PEL that demonstrates peripheral lymph node involvement at diagnosis and the first report of PEL in an Israeli patient.


Radiotherapy and Oncology | 2008

Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy.

Laurence Valeyrie-Allanore; Nicolas Poulalhon; Jean-Paul Fagot; Peggy Sekula; Batya Davidovici; Alexis Sidoroff; Maja Mockenhaupt

Amifostine is an organic thiophosphate prodrug used for cytoprotection against toxic effects of radiotherapy and chemotherapy. In a European prospective study of SJS/TEN, six patients were suspected to have SJS/TEN associated with amifostine. Our findings suggest that the risk of life-threatening cutaneous adverse reactions to amifostine could be significantly increased.


British Journal of Dermatology | 2010

The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102 cases: Histopathological features in AGEP

Sima Halevy; Sylvia H. Kardaun; Batya Davidovici; J. Wechsler

Background  Acute generalized exanthematous pustulosis (AGEP) is a rare severe pustular reaction pattern with a typical clinical picture.


Journal of the National Cancer Institute | 2001

Seroepidemiology and Molecular Epidemiology of Kaposi's Sarcoma-Associated Herpesvirus Among Jewish Population Groups in Israel

Batya Davidovici; Isabella Karakis; Dimitra Bourboulia; Samuel Ariad; Jian Chao Zong; Daniel Benharroch; Nicolas Dupin; Robin A. Weiss; Gary S. Hayward; Batia Sarov; Chris Boshoff


Journal of The American Academy of Dermatology | 2006

Acute generalized exanthematous pustulosis following a spider bite: Report of 3 cases

Batya Davidovici; Dyachenko Pavel; Emanuela Cagnano; Dganit Rozenman; Sima Halevy


Israel Medical Association Journal | 2008

Profile of Acute Generalized Exanthematous Pustulosis in Israel During 2002-2005: Results of the RegiSCAR Study

Batya Davidovici; Roni P. Dodiuk-Gad; Dganit Rozenman; Sima Halevy


Israel Medical Association Journal | 2008

Onychomycosis : Rationalization of Topical Treatment

Avner Shemer; Henri Trau; Batya Davidovici; Boaz Amichai; Marcelo H. Grunwald

Collaboration


Dive into the Batya Davidovici's collaboration.

Top Co-Authors

Avatar

Sima Halevy

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Sylvia H. Kardaun

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Boaz Amichai

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Daniel Benharroch

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Dganit Rozenman

Hebrew University of Jerusalem

View shared research outputs
Top Co-Authors

Avatar

Marcelo H. Grunwald

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Samuel Ariad

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicolas Dupin

Paris Descartes University

View shared research outputs
Researchain Logo
Decentralizing Knowledge